Showing results (931-940 of 9,403) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|May 3, 2018
Monotherapy Is Good Enough for Patients with Mild-to-Moderate Alzheimer's Disease: A Network Meta-analysis of 76 Randomized Controlled TrialsKelvin Kf Tsoi, Joyce Yc Chan, Felix Ch Chan, et al.Clinical Pharmacology and Therapeutics|August 2, 2018
Challenges and Opportunities for Improving the Safety Assessment of Botanical Dietary Supplements: A United States Pharmacopeia PerspectiveHellen A Oketch-Rabah, Amy L Roe, Kristi Muldoon-Jacobs, et al.Clinical Pharmacology and Therapeutics|August 15, 2018
Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment PuzzleImke H Bartelink, Ella F Jones, Sheerin K Shahidi-Latham, et al.Clinical Pharmacology and Therapeutics|August 21, 2018
Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive PropertiesAlexander W Krug, Sandra A G Visser, Kuenhi Tsai, et al.Clinical Pharmacology and Therapeutics|August 19, 2018
Industry Actions to Address Quality Issues for Dietary Supplements, Botanicals, and Other Natural ProductsJ Shenkar, James C GriffithsClinical Pharmacology and Therapeutics|August 18, 2018
Lipid Lowering Therapy for Atherosclerotic Cardiovascular Disease: It Is Not So SimpleJohn VincentClinical Pharmacology and Therapeutics|January 25, 2022
Functional Loss and Mortality in Randomized Clinical Trials for Amyotrophic Lateral Sclerosis: To Combine, or Not to Combine-That is the EstimandRuben P A van Eijk, Kit C B Roes, Inez de Greef-van der Sandt, et al.Clinical Pharmacology and Therapeutics|January 25, 2022
Development of a Generic Physiologically-Based Pharmacokinetic Model for Lactation and Prediction of Maternal and Infant Exposure to Ondansetron via Breast MilkKathleen M Job, André Dallmann, Samuel Parry, et al.Clinical Pharmacology and Therapeutics|October 1, 1976
Pharmacokinetics of oxprenolol in normal subjectsW D Mason, N WinerPageof 941